Benson Wealth Management’s AbbVie ABBV Stock Holding History

Benson Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.01K	Hold	8	–	–	﹤0.01%	283
2026 Q1	$1.74K	Hold	8	–	–	﹤0.01%	283
2025 Q4	$1.83K	Buy	+8	New	+$1.82K	﹤0.01%	272

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Benson Wealth Management's ABBV Position: Q2 2026 in Review

Benson Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 8 shares worth $2.01K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Benson Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Benson Wealth Management held 8 shares of AbbVie worth $2.01K as of Q2 2026.
Benson Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up ﹤0.01% of Benson Wealth Management's portfolio in Q2 2026, its #283 holding.
Benson Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Benson Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.